Table 3.
Structure | Stage | Variable(s) | F | df1 | df2 | p | Power | |
---|---|---|---|---|---|---|---|---|
GCC | Acute | CMB | 1.20 | 7 | 11 | 0.38 | 0.43 | 0.31 |
Age | 1.82 | 45 | 11 | 0.14 | 0.88 | 0.64 | ||
Sex | 0.67 | 2 | 10 | 0.54 | 0.12 | 0.13 | ||
Sex × age | 0.64 | 6 | 11 | 0.70 | 0.26 | 0.17 | ||
CMBs × age | 1.38 | 22 | 11 | 0.30 | 0.73 | 0.45 | ||
Chronic | CMB | 0.73 | 7 | 11 | 0.65 | 0.32 | 0.19 | |
Age | 5.52 | 46 | 11 | 0.01 | 0.96 | 1.00 | ||
Sex | 0.16 | 2 | 10 | 0.86 | 0.03 | 0.07 | ||
Sex × age | 3.92 | 6 | 11 | 0.02 | 0.68 | 0.81 | ||
CMB × age | 3.02 | 21 | 11 | 0.03 | 0.85 | 0.85 | ||
BCC | Acute | CMB | 1.14 | 7 | 11 | 0.41 | 0.42 | 0.29 |
Age | 2.61 | 45 | 11 | 0.04 | 0.91 | 0.83 | ||
Sex | 0.01 | 3 | 9 | 1.00 | 0.00 | 0.05 | ||
Sex × age | 1.85 | 6 | 11 | 0.18 | 0.50 | 0.45 | ||
CMB × age | 1.00 | 22 | 11 | 0.53 | 0.67 | 0.33 | ||
Chronic | CMB | 3.33 | 7 | 11 | 0.04 | 0.68 | 0.76 | |
Age | 3.99 | 46 | 11 | 0.01 | 0.94 | 0.96 | ||
Sex | 1.04 | 3 | 9 | 0.42 | 0.26 | 0.20 | ||
Sex × age | 1.68 | 6 | 11 | 0.22 | 0.48 | 0.41 | ||
CMB × age | 1.89 | 21 | 11 | 0.14 | 0.78 | 0.61 | ||
SCC | Acute | CMB | 0.61 | 7 | 11 | 0.74 | 0.28 | 0.17 |
Age | 1.34 | 45 | 11 | 0.31 | 0.85 | 0.48 | ||
Sex | 0.03 | 2 | 10 | 0.97 | 0.01 | 0.05 | ||
Sex × age | 0.46 | 6 | 11 | 0.82 | 0.20 | 0.13 | ||
CMB × age | 0.61 | 22 | 11 | 0.85 | 0.55 | 0.20 | ||
Chronic | CMB | 1.14 | 7 | 11 | 0.41 | 0.42 | 0.29 | |
Age | 2.33 | 46 | 11 | 0.06 | 0.91 | 0.78 | ||
Sex | 1.20 | 2 | 10 | 0.34 | 0.19 | 0.21 | ||
Sex × age | 1.37 | 6 | 11 | 0.31 | 0.43 | 0.34 | ||
CMB × age | 1.79 | 21 | 11 | 0.16 | 0.77 | 0.58 | ||
ILF | Acute | CMB | 1.82 | 7 | 11 | 0.18 | 0.54 | 0.46 |
Age | 2.49 | 45 | 11 | 0.05 | 0.91 | 0.81 | ||
Sex | 0.24 | 2 | 10 | 0.79 | 0.05 | 0.08 | ||
Sex × age | 1.11 | 6 | 11 | 0.42 | 0.38 | 0.27 | ||
CMB × age | 1.91 | 22 | 11 | 0.13 | 0.79 | 0.62 | ||
Chronic | CMB | 2.75 | 7 | 11 | 0.07 | 0.64 | 0.66 | |
Age | 1.03 | 46 | 11 | 0.52 | 0.81 | 0.37 | ||
Sex | 0.46 | 2 | 10 | 0.64 | 0.08 | 0.11 | ||
Sex × age | 2.16 | 6 | 11 | 0.13 | 0.54 | 0.52 | ||
CMB × age | 1.21 | 21 | 11 | 0.39 | 0.70 | 0.39 | ||
MdLF | Acute | CMB | 1.53 | 7 | 11 | 0.25 | 0.49 | 0.39 |
Age | 1.20 | 45 | 11 | 0.39 | 0.83 | 0.43 | ||
Sex | 1.15 | 2 | 10 | 0.35 | 0.19 | 0.20 | ||
Sex × age | 0.89 | 6 | 11 | 0.53 | 0.33 | 0.22 | ||
CMB × age | 1.24 | 7 | 11 | 0.37 | 0.71 | 0.41 | ||
Chronic | CMB | 3.34 | 45 | 11 | 0.04 | 0.68 | 0.76 | |
Age | 2.61 | 2 | 10 | 0.04 | 0.92 | 0.83 | ||
Sex | 0.85 | 6 | 11 | 0.45 | 0.15 | 0.16 | ||
Sex × age | 0.85 | 22 | 11 | 0.56 | 0.32 | 0.21 | ||
CMB × age | 1.51 | 7 | 11 | 0.24 | 0.74 | 0.49 | ||
IOFF | Acute | CMB | 0.52 | 46 | 11 | 0.81 | 0.25 | 0.15 |
Age | 1.09 | 45 | 11 | 0.47 | 0.82 | 0.39 | ||
Sex | 1.11 | 2 | 10 | 0.37 | 0.18 | 0.19 | ||
Sex × age | 1.11 | 6 | 11 | 0.42 | 0.38 | 0.27 | ||
CMB × age | 1.17 | 22 | 11 | 0.41 | 0.70 | 0.38 | ||
Chronic | CMB | 0.71 | 7 | 11 | 0.66 | 0.31 | 0.19 | |
Age | 1.06 | 46 | 11 | 0.49 | 0.82 | 0.38 | ||
Sex | 1.46 | 2 | 10 | 0.28 | 0.23 | 0.24 | ||
Sex × age | 0.83 | 6 | 11 | 0.57 | 0.31 | 0.21 | ||
CMB × age | 1.16 | 21 | 11 | 0.41 | 0.69 | 0.38 | ||
Sup-F | Acute | CMB | 1.35 | 7 | 11 | 0.31 | 0.46 | 0.35 |
Age | 1.59 | 45 | 11 | 0.21 | 0.87 | 0.57 | ||
Sex | 0.31 | 2 | 10 | 0.74 | 0.06 | 0.09 | ||
Sex × age | 1.23 | 6 | 11 | 0.36 | 0.40 | 0.30 | ||
CMB × age | 2.15 | 22 | 11 | 0.09 | 0.81 | 0.68 | ||
Chronic | CMB | 2.55 | 7 | 11 | 0.08 | 0.62 | 0.62 | |
Age | 2.50 | 46 | 11 | 0.05 | 0.91 | 0.81 | ||
Sex | 1.83 | 2 | 10 | 0.21 | 0.27 | 0.29 | ||
Sex × age | 2.74 | 6 | 11 | 0.07 | 0.60 | 0.63 | ||
CMB × age | 1.79 | 21 | 11 | 0.16 | 0.77 | 0.58 | ||
Sup-T | Acute | CMB | 1.10 | 7 | 11 | 0.43 | 0.41 | 0.28 |
Age | 1.90 | 45 | 11 | 0.12 | 0.89 | 0.67 | ||
Sex | 1.99 | 2 | 10 | 0.19 | 0.29 | 0.32 | ||
Sex × age | 1.10 | 6 | 11 | 0.42 | 0.38 | 0.27 | ||
CMB × age | 1.36 | 22 | 11 | 0.30 | 0.73 | 0.45 | ||
Chronic | CMB | 3.69 | 7 | 11 | 0.03 | 0.70 | 0.81 | |
Age | 2.42 | 46 | 11 | 0.06 | 0.91 | 0.79 | ||
Sex | 0.54 | 2 | 10 | 0.60 | 0.10 | 0.12 | ||
Sex × age | 1.86 | 6 | 11 | 0.18 | 0.50 | 0.45 | ||
CMB × age | 2.10 | 21 | 11 | 0.10 | 0.80 | 0.66 | ||
Sup-P | Acute | CMB | 2.86 | 7 | 11 | 0.06 | 0.65 | 0.68 |
Age | 1.62 | 45 | 11 | 0.19 | 0.87 | 0.58 | ||
Sex | 0.27 | 2 | 10 | 0.77 | 0.05 | 0.08 | ||
Sex × age | 1.68 | 6 | 11 | 0.22 | 0.48 | 0.41 | ||
CMB × age | 0.90 | 22 | 11 | 0.60 | 0.64 | 0.29 | ||
Chronic | CMB | 1.05 | 7 | 11 | 0.45 | 0.40 | 0.27 | |
Age | 1.11 | 46 | 11 | 0.46 | 0.82 | 0.40 | ||
Sex | 0.16 | 2 | 10 | 0.85 | 0.03 | 0.07 | ||
Sex × age | 2.02 | 6 | 11 | 0.15 | 0.52 | 0.49 | ||
CMB × age | 0.96 | 21 | 11 | 0.56 | 0.65 | 0.31 | ||
CST | Acute | CMB | 1.14 | 7 | 11 | 0.41 | 0.42 | 0.29 |
Age | 1.53 | 45 | 11 | 0.23 | 0.86 | 0.55 | ||
Sex | 1.16 | 2 | 10 | 0.35 | 0.19 | 0.20 | ||
Sex × age | 0.72 | 6 | 11 | 0.65 | 0.28 | 0.18 | ||
CMB × age | 1.10 | 22 | 11 | 0.46 | 0.69 | 0.36 | ||
Chronic | CMB | 1.20 | 7 | 11 | 0.38 | 0.43 | 0.31 | |
Age | 1.01 | 46 | 11 | 0.53 | 0.81 | 0.36 | ||
Sex | 0.69 | 2 | 10 | 0.52 | 0.12 | 0.14 | ||
Sex × age | 1.19 | 6 | 11 | 0.38 | 0.39 | 0.29 | ||
CMB × age | 1.62 | 21 | 11 | 0.21 | 0.76 | 0.53 |
The acute and chronic time points correspond to 7 days and 6 months post-injury, respectively. Null hypotheses were tested at a significance level of = 0.05, and findings that are both significant and well-powered (power > 0.8) are in bold case. F statistics, numerator and denominator degrees of freedom (df1 and df2), effect sizes (Cohen’s ), and statistical power are listed
BCC, body of the corpus callosum; CMB, cerebral microbleed; CST, corticospinal tract; FA, fractional anisotropy; GCC, genu of the corpus callosum; ILF , inferior longitudinal fasciculus; IOFF, inferior occipitofrontal fasciculus; MdLF, middle longitudinal fasciculus; SCC , splenium of the corpus callosum; Sup-F, superficial frontal; Sup-P, superficial parietal; Sup-T, superficial temporal; WM, white matter